MIRACLE-Leukemia is a Marie Skłodowska-Curie doctoral network and aims to combat MRD to improve leukemia treatment. MIRACLE stands for "Integrated multi-angle research and training network to eradicate leukemia minimal residual disease." The MIRACLE-leukemia network consists of 23 partners and will employ 10 talented researchers (doctoral candidates) that will perform cutting-edge studies across academic and industrial settings while having training in multidisciplinary and transferable skills.
MIRACLE is funded by the European Union's Horizon Europe's Research and Innovation Program under the Marie Sklodowska- Curie Actions Grant Agreement nr. 101167512.
Legal notice and privacy
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.
